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Abstract. In this paper, we show that [3COP is present 
on endosomes and is required for the formation of vesi- 
cles which mediate transport from early to late endo- 
somes. Both the association of 13COP to endosomal 
membranes as well as transport vesicle formation de- 
pend on the lumenal pH. We find that ~COP, but not 
",/COP, is also associated to endosomes, and that this as- 
sociation is also lumenal pH dependent. Our data, thus, 
indicate that a subset of COPs is part of the mechanism 
regulating endosomal membrane transport, and that 
membrane association of these COPs is controlled by 
the acidic properties of early endosomes, presumably 
via a trans-membrane pH sensor. 
T 
HE cytoplasmic surface of some subcellular com- 
partments and vesicles is known to be coated by 
specific sets of peripheral membrane proteins (Kreis 
and Pepperkok, 1994), including clathrin and adaptor pro- 
teins (Pearse and Robinson, 1990), COP coatomers (Roth- 
man and Orci, 1992) and COPII proteins (Barlowe et al.,
1994). Although the proteins which constitute ach coat 
are clearly distinct, sequence homologies have been found 
between some clathrin-associated a aptor proteins and 
COP coatomers (Duden et al., 1991; Kuge et al., 1993). 
Clathrin is part of the coat of at least two distinct popu- 
lations of vesicles, which mediate transport from the 
plasma membrane and from the TGN to endosomes (Rob- 
inson, 1992). In addition to clathrin, the coat of each vesi- 
cle population is formed by a complex of specific, but ho- 
mologous, adaptor proteins, AP1 and AP2 on TGN- and 
plasma membrane-derived vesicles, respectively. Both 
COP and COPII are involved at early stages of the biosyn- 
thetic pathway. COPs are required for the formation of 
Golgi-derived vesicles (Orci et al., 1986; Ostermann et al., 
1993) and for membrane transport from the intermediate 
compartment to the Golgi complex (Pepperkok et al., 
1993). In yeast, however, formation of ER-derived vesicles 
requires COPII (Barlowe et al., 1994), as well as the small 
GTP-binding protein Sarlp (D'Enfert et al., 1991). In ad- 
dition, Sarlp also promotes vesicle budding from the ER, 
but not the Golgi, in mammalian cells (Kuge et al., 1994). 
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Thus, the COP and COPII coats may be associated to ei- 
ther two parallel or two sequential transport steps from 
the ER to the Golgi. These coats may also support rans- 
port in opposite directions, as suggested by recent studies 
showing that retrieval of di-lysine tagged proteins to the 
ER depends on COPs (Letourneur et al., 1994). 
Except for the AP2/clathrin coat at the plasma mem- 
brane, relatively little is known about the possible involve- 
ment of coat proteins in the endocytic pathway. At the 
electron microscope level, early endosomal membranes 
were shown to c ntain clathrin-coated pits with a diameter 
smaller than on the plasma membrane; these pits were 
proposed to mediate membrane r cycling back to the cell 
surface (Killisch et al., 1992). Nonclathrin-coated domains 
have also been observed on early endosomal membranes 
(Par*on, R., unpublished result), but the identity and role 
of these putative coat proteins are unknown. Whereas 
GTP-binding proteins of the ARF/sar family regulate coat 
assembly at different steps of the biosynthetic pathway 
(D'Enfert et al., 1991; Orci et al., 1993a; Stammes and 
Rothman, 1993), their role in the endocytic pathway is not 
clear. In vitro studies may suggest that an ARF protein is 
involved in endosome fusion (Lenhard et al., 1992), while 
overexpression f a mutant ARF6 defective in nucleotide 
binding caused accumulation of nonclathrin-coated struc- 
tures on peripheral tubules, and reduced transferrin- 
receptor recycling (D'Souza-Schorey t al., 1994; Peters et 
al., 1994). Brefeldin A, a drug which inhibits the Golgi- 
associated ARF1 exchange factor (Donaldson et al., 1992; 
Helms and Rothman, 1992), was shown to affect the mor- 
phology of endosomes (Lippincott-Schwartz et al., 1991; 
Tooze and Hollinshead, 1991; Wood and Brown, 1992), 
but the molecular events causing these changes are not 
clear. Finally, expression of ~COP, a component of the 
COP coat (Hara-Kuge t al., 1994), could correct pleiotro- 
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pic transport defects, including in the endocytic pathway, 
in a mutant CHO cell line (Guo et al., 1994). 
In previous tudies, we have observed that tracers en- 
docytosed in BHK cells first appear in early endosomes, 
then in intermediate vesicles with the typical morphology 
of multivesicular endosomes, and finally in late endosomes 
(Gruenberg et al., 1989). Our in vitro studies indicate that 
these vesicles, which we term endosomal carrier vesicles 
(ECVs) 1, are obligatory transport intermediates between 
early and late endosomes, ince ECVs are only fusogenic 
with late endosomes, but not with early endosomes nor 
with each other (Gruenberg et al., 1989; Bomsel et al., 
1990; Aniento et al., 1993a). We also observed that neu- 
tralization of the vacuolar pH with bafilomycin A1, a spe- 
cific inhibitor of the vacuolar ATPase (Bowman et al., 
1988), blocks ECV formation in vivo (Clague t al., 1994). 
The former treatment had no effect on internalization i to 
and recycling from early endosomes in vivo, or on endo- 
some fusion properties in vitro. In the present paper, we 
have investigated the mechanisms of ECV formation from 
early endosomes using an in vitro assay. Our data show 
that ~COP is associated to early endosomes and is in- 
volved in ECV formation. Our observations also suggest 
that some, but not all, COPs are involved in this process, 
and that coat formation is controlled by the acidic proper- 
ties of early endosomes, presumably via a trans-membrane 
pH sensor. 
Materials and Methods 
Cells, Viruses, and Immunological Reagents 
Monolayers of BHK-21 cells were grown and maintained as described 
(Gruenberg et al., 1989). For each experiment, a minimum of 6 × 10 cm 
Petri dishes were seeded 16 h before use. Vesicular stomatitis virus (VSV) 
was produced as described (Gruenberg et al., 1989). All manipulations of
the cells were at 4°C, except when indicated. The P5D4 monoclonal anti- 
body against the cytoplasmic domain of the spike glycoprotein G of VSV 
(Kreis, 1986) was a gift of T. Kreis (University of Geneva, Geneva, Swit- 
zerland), as well as the M3A5, maD, A1, El, and D1 antibodies against 
13COP peptides (Allan and Kreis, 1986; Pepperkok et al., 1993). The 
CM1A10 anti-coatomer antibody (Orci et al., 1993b) and the anti-~COP 
antibody (Hara-Kuge t al., 1994) were gifts from J. Rothman (Sloan-Ket- 
tering Institute, New York, NY). The antibody against ~COP (Stenbeck et 
al., 1992) was a gift from F. Wieland (Ruprecht Karls University, Heidel- 
berg, Germany). The antibody against ERGIC53 was a gift from H.-P. 
Hauri (Biocenter, Basel, Switzerland). The monoclonal antibodies against 
rab5a and rab3a were gifts from R. Jahn (Yale University, New Haven, 
CT), and the monoclonal antibody against he transferrin receptor was a 
gift from I. Trowbridge (Salk Institute, San Diego, CA). The antibody 
against annexinII was a gift from V. Gerke (University of MOnster, MOn- 
ster, Germany). 
Subcellular Fractionation of Endosomes 
Endosomes were separated from each other and from the plasma mem- 
brane using a step flotation gradient, as described (Chavrier et al., 1991; 
Gorvel et al., 1991; Aniento et al., 1993a; Emans et al., 1993). Briefly, cells 
were homogenized gently to limit damage that may be caused to endo- 
somes, and a postnuclear supernatant (PNS) was prepared. The PNS was 
adjusted to 40.6% sucrose, 3 mM imidazole, pH 7.4, loaded at the bottom 
of an SW60 tube, and then overlaid sequentially with 35 and 25% sucrose 
solutions in 3 mM imidazole, pH 7.4, and then with homogenization buffer 
1. Abbreviations u ed in this paper: bHRP, biotinylated HRP; ECV, endo- 
somal carrier vesicle; FI r, floated fraction; HB, homogenization buffer; 
HSP, high-speed pellet; PF, pelleted fraction; PNS, postnuclear superna- 
tant; VSV, vesicular stomatitis virus. 
(HB; 250 mM sucrose, 3 mM imidazole, pH 7.4). The gradient was centri- 
fuged for 60 min at 35,000 rpm using an SW60 rotor. Early endosomes 
were then collected at the 35%/25% interface and both ECVs and late en- 
dosomes at the 25%/HB interface. In immunoisolation experiments, en- 
dosomal fractions were prepared using the same gradient, except that 
16% sucrose and 10% sucrose in D20 were used instead of 35 and 25% 
sucrose, respectively (Gorvel et al., 1991). 
Early and late endosomes were immunoisolated using as antigen the 
cytoplasmic domain of the spike glycoprotein G of VSV (Gruenberg et al., 
1989; Howell et al., 1989; Aniento et al., 1993a; Emans et al., 1993). 
Briefly, the G protein was implanted into the plasma membrane by low 
pH-mediated fusion of the viral envelope with the plasma membrane and 
then internalized for 5 min at 37°C to label early endosomes or for 45 min 
at 37°C to label late endosomes. The cells were then homogenized and 
fractionated in the gradient, as described above. Early and late endosomal 
fractions were collected and used as input in immunoisolation experi- 
ments. For immunoisolation, weused magnetic beads (M-450 Dynabeads) 
with coupled antibodies against mouse IgG as solid support and the P5D4 
antibody against the cytoplasmic domain of the G protein as specific anti- 
body (Kreis, 1986). Alternatively, endosomes were immunoisolated using 
the maD or the M3A5 antibody against 13COP as specific antibody. 
In Vitro Formation ofECVs from Early Endosomes 
To provide a marker of the early endosomal content (Aniento et al., 
1993a; Emans et al., 1993; Gruenberg et al., 1989), cells were incubated for 
5 min in the presence of 5 mg/ml HRP. The cells were then homogenized 
and early endosomes were separated from ECVs and late endosomes af- 
ter flotation on the gradient (see above). The early endosomal fraction 
was then diluted to ~0.2 mg protein/ml with HB, adjusted to 12.5 mM 
Hepes, pH 7.0, 1 mM DTF, 1.5 mM MgOAc, 60 mM KCI, and supple- 
mented with an ATP regenerating system (Gruenberg and Howell, 1986) 
and 4 mg/ml rat liver cytosol (Aniento et al., 1993b). In the assay, the mix- 
ture, containing 300-500 l~g of early endosomal protein in a final volume 
of 1.4-2.3 ml, was incubated for 30 min at 37°C. After the incubation, the 
mixture containing both donor early endosomes and vesicles formed in 
vitro was brought o 25% sucrose, 3 mM imidazole, pH 7.4, loaded at the 
bottom of an SW60 tube and overlaid with HB. After 1 h centrifugation at
35,000 rpm, donor early endosomes (pelleted fraction; PF) and budded 
vesicles (floated fraction; FF) were recovered from the pellet and the 25 % 
sucrose/HB interface, respectively. Both fractions were re-centrifuged for 
30 min at 100,000 g to sediment membranes, and the HRP activity was 
quantified in the pellets. For SDS gel electrophoresis, membranes were 
washed during a second centrifugation step in HB containing 150 mM 
NaCI to remove loosely bound cytosolic factors, before solubilization in 
gel sample buffer. 
In some experiments, the cytosol was depleted of coatomer using the 
CM1A10 anti-coatomer antibody, as reported by Orci et al. (1993b). The 
cytosol was incubated with the antibody for 90 min at 4°C and then for an 
additional 60-rain time period with protein A~Sepharose coupled to rab- 
bit anti-mouse IgG. After removal of the immune complex, both 13 and 
eCOP were reduced to -~15-20% of the original amounts. In controls, the 
anti-13COP antibody was replaced by an irrelevant antibody (P5D4). A 
fraction highly enriched in coatomer was prepared by high speed centrifu- 
gation (200,000 g, 2 h) of rat liver cytosol, as established by F. Wieland 
(Ruprecht Karls University, Heidelberg, Germany). The high-speed su- 
pernatant then retained only ~-20% of both 13 and eCOP. The high-speed 
pellet (HSP) enriched in coatomer was resuspended in HB and used in the 
assay. 
In Vitro Fusion of ECVs with Late Endosomes 
The fusion properties of vesicles formed in vitro were measured using an 
assay we have established (Gruenberg et al., 1989; Bomsel et al., 1990; 
Gorvel et al., 1991; Aniento et al., 1993a). Formation of vesicles in vitro 
was as above, except that biotinylated HRP (bHRP) was used to label the 
vesicle content, instead of HRP. Then, ECVs formed in vitro were sepa- 
rated from donor membranes by flotation as described above, except that 
the reaction mixture was loaded onto a 35% sucrose cushion in 3 mM imi- 
dazole, pH 7.4, to avoid pelleting of the donor membranes. Thus, donor 
early endosomal membranes (PF) were collected at the interface between 
35 and 25% sucrose, and ECVs formed in vitro (FF) at the interface be- 
tween 25% sucrose and homogenization buffer. In control experiments, 
early endosomes labeled with bHRP internalized for 5 min at 37°C were 
prepared as above using the gradient. The total bHRP activity of each 
fraction used in the fusion assay was always identical, so that experiments 
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could be directly compared. In parallel, early or late endosomes were la- 
beled with avidin after incubation at 37°C for 5 min, or 5 min followed by 
a 40-rain chase in marker-free medium, respectively (Gruenberg et al., 
1989; Gorvel et ai., 1991; Aniento et al., 1993a). After homogenization, a 
PNS was prepared and used in the fusion assay, as described (Gruenberg 
et al., 1989). In the assay, bHRP-labeled vesicles formed in vitro (50 p,1 
containing 5-10 p,g protein) were mixed with 70 p~l PNS containing avidin- 
labeled endosomes, and then supplemented with 30 Ixl rat liver cytosol 
(20 mg protein/ml), an ATP-regenerating or -depleting system, 0.05 mg/ml 
biotinylated insulin, 60 mM KOAc, 1.5 mM MgOAc, 1 mM DTT, and 12.5 
mM Hepes, pH 7.4, and the mixture was incubated for 45 min at 37°C. In 
some experiments, endogenous tubulin was polymerized in the assay us- 
ing 20 IxM taxol (Bomsel et al., 1990; Aniento et al., 1993a). Then the avi- 
din-bHRP complex formed upon membrane fusion was extracted in de- 
tergent, immunoprecipitated with anti-avidin antibodies and the enzymatic 
activity of bHRP was quantified. To calculate fusion efficiency, this value 
was expressed as a percentage of the total amount of avidin-bHRP com- 
plex formed in the presence of detergent and in the absence of biotiny- 
lated insulin. 
Electron Microscopy 
For electron microscopic localization studies, BHK cells were grown on 
polylysine-coated coverslips for 2 d before the experiment. The cells were 
washed and incubated with 10 mg/ml HRP for 10 min at 37°C to label 
early endosomes. They were then washed with cold PBS and transferred 
to ice. Rip-off of the dorsal surface was performed as described by De 
Curtis and Simons (1989). Briefly, a nitrocellulose filter was laid on top of 
the coverslips in contact with the cells. After applying slight pressure to 
the nitrocellulose using a bent glass pipette, the nitrocellulose was re- 
moved. All the following steps, before fixation, were performed on ice. 
The cells were then incubated for 10 min in 12.5 mM Hepes, pH 7.0 buffer, 
containing 75 mM KC1, 1.5 mM MgOAc and 0.1% BSA, and then incu- 
bated in the same buffer for 30 rain with either the M3A5 anti-13COP anti- 
body or with a control monoclonal antibody at exactly the same concen- 
tration. After washing the cells over 30 min, they were then incubated 
with gold-labeled second antibodies (Aurion, Wageningen, The Nether- 
lands). The cells were washed to remove unbound gold, fixed in 2.5% glu- 
taraldehyde in 50 mM cacodylate, and then processed for Epon embed- 
ding as previously described (Parton et al., 1992). Sections were cut 
parallel to the substratum and viewed without further contrasting. 
When analyzed in plastic sections, fractions containing HRP-labeled 
donor membranes (PF) or vesicles formed in vitro (FF) were prepared as 
described above, and centrifuged for 30 min at 100,000 g. The membrane 
pellets were fixed, reacted with diaminobenzidine, and processed for elec- 
tron microscopy as described (Parton et al., 1989; Bomsel et al., 1990). In 
some experiments, the assay measuring vesicle formation was carried out 
in the presence of GTP~S and M3A5 anti-13COP antibody. Then, rabbit 
anti-mouse IgG and protein A-gold were added. Membranes were col- 
lected by centrifugation i  a sucrose step flotation gradient at the 35-10% 
interface and then re-centrifuged for 30 min at 100,000 g. The membrane 
pellets were fixed, reacted with diaminobenzidine, and processed for elec- 
tron microscopy. 
Analytical Techniques 
Quantification of protein was according to (Bradford, 1976). Western blot 
analysis was carried out using peroxidase-conjugated sh ep anti-mouse or 
goat anti-rabbit IgG as secondary antibodies and detected by chemilumi- 
nescence using the ECL reagent (Amersham Corp., Arlington Heights, 
IL). Western blots exposed in the linear range of detection, as established 
with controls, were quantitated using a GS300 transmitance/reflectance 
scanning densitometer (Hoefer Scientific Instruments, San Francisco, CA). 
Results 
flCOP (or a Closely Related Homologue) Is Present in 
Endosomal Fractions 
We have tested whether 13COP could be detected on en- 
dosomes of BHK cells. As a first step, we have analyzed 
endosomal fractions obtained by flotation in a step gradi- 
ent which we have established. In this gradient, early en- 
dosomes, containing annexinlI and the small GTPase 
rab5, equilibrate at the interface between two cushions of 
35 and 25% sucrose, whereas late endosomes, containing 
the rab7 protein as well as the mannose-6-phosphate re- 
ceptor and lysosomal glycoproteins, are found at a lighter 
position corresponding to the interface between 25 and 
8.5% sucrose (Chavrier et al., 1991; Gorvel et al., 1991; 
Aniento et al., 1993a; Emans et al., 1993). A detailed anal- 
ysis of the in vitro fusion properties and protein composi- 
tion of these fractions revealed that ECVs equilibrate at 
the same position as late endosomes (Aniento et al., 
1993a). 
A Western blot analysis revealed the presence of pro- 
teins migrating at the position of 13COP and ¢COP in both 
early and late endosomal fractions (Fig. 1 A, EE and LE, 
respectively). In contrast, these fractions did not contain 
detectable amounts of ~/COP. Previously, the bulk of 13COP 
was shown to localize to early stages of the biosynthetic 
pathway after immunogold labeling of cryosections using 
an antibody raised against a 13COP peptide (Duden et al., 
1991; Pepperkok et al., 1993). We therefore analyzed the 
distribution of the intermediate compartment between ER 
and Golgi in our gradient, using antibodies against ERGIC53 
(Schweizer et al., 1988). The bulk of ERGIC53, I~COP, 
and ¢COP was recovered, as expected, in the same frac- 
tion (heavy membranes, Fig. 1 A, HM), at the interface be- 
tween the load and the 35% sucrose cushion, well sepa- 
rated from endosomes. Quantification of the gels showed 
that the early endosomal fraction contained only -~10% of 
the amounts of ERGIC53 present in the HM fraction and 
<5% of 7COP, but 55-70% of ¢ and 13COP (Fig. 1 B). It 
is, however, not clear whether these values really reflect 
the intracellular distribution of 13 and ~COP, or whether 
the endosomal forms of these proteins are preferentially 
recognized by the antibodies we used. Moreover, both 
and 13COP were also present in late endosomal fractions, 
but neither ERGIC53 nor ~/COP (even after long expo- 
sures of the gels). To ensure that the presence of COPs in 
endosomal fractions did not reflect spurious membrane as- 
sociation of the protein after homogenization, we pre- 
pared mitochondria nd Golgi/endosome fractions from 
rat liver (Aniento et al., 1993b). A Western blot analysis 
showed that 13COP was indeed present in the latter frac- 
tion, as expected, but absent from the mitochondrial frac- 
tion (not shown). These observations may suggest hat 13 
and ¢COP, but not ~/COP, are associated to endosomes. 
Immunoisolation fEarly Endosomes 
We then used immunoisolation to determine whether 13 
and ~COP were indeed present on early endosomes 
(Gruenberg et al., 1989; Howell et al., 1989; Aniento et al., 
1993a; Emans et al., 1993). The spike glycoprotein G of 
VSV was implanted into the plasma membrane by low 
pH-mediated fusion of the viral envelope with the plasma 
membrane, and then internalized for 5 rain at 37°C to label 
early endosomes. After homogenization, endosomes were 
fractionated on the gradient and then immunoisolated on 
magnetic beads (Dynabeads M-450) with bound antibod- 
ies against he cytoplasmic domain of the G protein (Kreis, 
1986). As shown in Fig. 1 A, both 13 and ¢COP, but neither 
ERGIC53 nor ~/COP, were specifically associated to im- 
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Figure 1. COPs in endosomal fractions. (A) The distribution 
of COPs and ERGIC53 was studied in BHK cytosol and in 
BHK subcellular f actions by SDS-PAGE followed by West- 
ern blotting, using antibodies against ERGIC53, ¢ or ~/COP, 
and the M3A5 antibody against [3COP. The PNS was loaded 
at the bottom of a sucrose flotation gradient, and, after cen- 
trifugation, fractions were collected: heavy membranes (HM), 
40.6%/35% interface; early endosomes (EE) 35%/25% inter- 
face; late endosomes (LE) 25% sucrose/homogenization 
buffer interface. In all lanes, 15 p,g protein was loaded. Early 
endosomes were further purified from 60 i~g EE fraction by 
immunoisolation (II-EE). Then, the VSV-G glycoprotein was 
implanted into the plasma membrane and then internalized 
for 5 min at 37°C. After the gradient, early endosomes were 
retrieved using anti-mouse magnetic beads without (control, 
ctrl.) or with the P5D4 antibody against VSV-G cytoplasmic 
domain (specific, sp.) (B) The distribution of ERGIC53, [3, ¢, 
and ~/COP in the gradient fractions (,4) was quantified by den- 
sitometric scanning of the blots. To facilitate comparison, the 
amounts of each marker present in the HM fraction was nor- 
malized to 100%. (C) Immunoisolated arly endosomes (II- 
EE in A) were incubated in vitro in the presence of 1 mg/ml 
BHK cytosol with (GTPyS) or without (control) 50 oLM 
GTP~/S, washed, and analyzed by SDS-PAGE followed by 
Western blotting with antibodies against [3 or ¢COP, as in A. 
(D) HRP was internalized for 5 min at 37°C and then cells 
were fractionated as in A, but immunoisolation was carried 
out with the following antibodies: No Ab, no antibody; P5D4, 
control with P5D4 antibody; anti-flll3radaptin, a tibody against 
both [31 and [32 adaptins; M3A5 and maD, antibodies against 
different [3COP peptides. The HRP activity associated to the 
beads was quantified and expressed as a percentage of the to- 
tal HRP activity originally present in the fraction. (E) As in D, 
but analysis was by SDS-PAGE and Western blotting with an- 
tibodies against he transferrin receptor (Tfn-R) or against 
rab5. For comparison, the starting early endosomal fraction 
(EE) was also analyzed, rab5 migrates at a position close to 
the light chain of the IgG used in immunoisolation (IgG 1.c.). 
munoisolated early endosomal membranes. We then tested 
whether [3 and eCOP association to endosomes was, as is 
the case in the biosynthetic pathway, sensitive to GTP~/S. 
As shown in Fig. 1 C, the amounts of [3 and ¢COP present 
on immunoisolated arly endosomes were significantly in- 
creased after incubation in the presence of cytosol and 
GTP~/S, indicating that COP recruitment onto endosomal 
or biosynthetic membranes share some mechanistic simi- 
larities. 
As a next step, we investigated whether early endo- 
somes could also be immunoisolated using two different 
anti-[3COP antibodies (M3A5 or maD). The antibodies 
were bound to the same solid support and the complex 
was added to endosomal fractions which had been col- 
lected from the gradient, as above. In these experiments, 
we used horseradish peroxidase internalized for 5 min at 
37°C as marker of the early endosomal content, and the 
transferrin receptor (Hopkins and Trowbridge, 1983; Trow- 
bridge et al., 1993) as well as the small GTPase rab5 
(Chavrier et al., 1990), as markers of early endosomal 
membranes. Fig. 1 (D and E) shows that the three markers 
were specifically retrieved with either anti-[3COP anti- 
body, but not with control antibodies nor with antibodies 
recognizing the clathrin-associated [31 adaptin as well as 
the [32 adaptin, which has some homology to [3COP 
(Duden et al., 1991). Altogether, these experiments show 
that [3 and ¢COP, but not ~/COP, are present on early en- 
dosomal membranes. 
Electron Microscopy Analysis of flCOP on 
Early Endosomes 
We then investigated whether [3COP could be detected on 
early endosomal membranes by electron microscopy. 
Since neither the M3A5 nor the maD antibody recognized 
their antigen on cryosections, we used a pre-embedding la- 
beling technique. Cells were first incubated in the pres- 
ence of HRP  for 10 rain at 37°C, to label the early endoso- 
mal lumen, and then the dorsal surface of the cells was tipped 
off with nitrocellulose (De Curtis and Simons, 1989) to 
gain access to the cytoplasm. The opened cells were then 
treated with the M3A5 antibody against [3COP followed 
by gold-labeled second antibody, and then the cells were 
processed for electron microscopy. Fig. 2 shows that the 
anti-[3COP antibody, but not the control antibody, specifi- 
cally labeled early endosomes containing internalized HRP. 
In Vitro Budding of Endosomal Carrier Vesicles 
The fact that 13 and eCOP were present in both early and 
late endosomal fractions (Fig. 1 A) suggested that these 
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Figure 2. Endosome localiza- 
tion of 13COP in permeabilized 
cells. Cells were incubated with 
HRP for 10 rain at 37°C to label 
early endosomes, and were then 
permeabilized. The permeabi- 
lized cells were then incubated 
with the M3A5 anti-13COP anti- 
body (A and B) or an irrelevant 
control antibody (C) followed 
by gold-labeled second antibod- 
ies. HRP-labeled endosomes are 
labeled by the anti-13COP anti- 
body (A and B, arrowheads) but 
not by control antibodies (C); 
gold particles indicated by ar- 
rowheads, HRP-labeled endo- 
some by an arrow. The rough 
endoplasmic reticulum (rer) and 
mitochondria (m) show lower la- 
beling with the M3A5 antibody 
(A and B). Bars, 100 nm. 
proteins may be involved in membrane transport between 
early and late endosomes. We, therefore, decided to estab- 
lish an in vitro assay measuring ECV formation and to 
make use of the large panel of antibodies available against 
[3COP to test whether the protein was involved in this 
process. 
Cells were incubated for 5 min at 37°C in the presence of 
HRP, to provide a marker of the early endosomal content. 
Early endosomes were then separated from the lighter 
ECVs and late endosomes, using the flotation gradient. In 
the assay, these early endosomal fractions were incubated 
at 37°C in the presence of ATP and cytosol, to allow for- 
mation of ECVs from early endosomes to occur in vitro. 
The mixture was then loaded on a similar flotation gradi- 
ent, to separate ECVs formed in vitro from the denser do- 
nor membranes (early endosomes). After centrifugation, 
the HRP activity of the FF (containing vesicles formed in 
vitro) and PF (containing donor membranes) was quanti- 
fied. Thus, the assay measures the percentage of the total 
early endosomal content entrapped within vesicles formed 
in the assay. 
As shown in Fig. 3 A, vesicle formation in vitro occurred 
at 37°C, but not at 4°C, and required both cytosol and 
ATP. The process was rapid (Fig. 3 B), like other budding 
events in vitro (Salamero et al., 1990; Tooze and Huttner, 
1990; Rexach and Schekman, 1991): within 5-10 min 
~10% of the original early endosomal volume was en- 
trapped within vesicles formed in vitro. We also observed 
that vesicle formation was inhibited by low concentrations 
of GTP~/S (Fig. 3 A and see Discussion). Addition of 
GTP~S, or any one of the other treatments, had no effect 
on the sedimentation properties of early or late endosomal 
membranes in continuous sucrose gradients (data not 
shown). Western blotting of SDS gels with two different 
anti-13COP antibodies showed that vesicles formed in vitro 
contained [3COP, as predicted (Fig. 3 C). The low amounts 
of ERGIC53 originally present in the early endosomal 
fraction (Fig. 1) remained associated to donor membranes 
after the assay (Fig. 3 C). Finally, ECVs formed in vitro 
contained <5% of the amounts of rab5 and transferrin re- 
ceptor emaining in donor membranes after the assay (Fig. 
3 C). These observations indicate that the floated fraction 
was not contaminated with early endosomal vesicles, and 
that both rab5 and the transferrin receptor were excluded 
from ECVs formed in vitro, as in vivo. These experiments 
also show that the floated fraction did not contain recy- 
cling vesicles destined to carry the transferrin receptor 
back to the plasma membrane. 
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Figure 3. In vitro formation 
of ECVs. (A) Early endo- 
somes containing HRP inter- 
nalized for 5 min at 37°C 
were prepared by flotation 
on a sucrose gradient, as in 
Fig. 1. In the assay, early en- 
dosomal fractions were di- 
luted with cytosol and incu- 
bated for 30 min at 37°C. 
Vesicles formed in vitro were 
then separated from donor 
early endosomes by flotation 
in a single step gradient. Af- 
ter centrifugation, early en- 
dosomes were recovered in 
the pellet, whereas vesicles 
formed in vitro were col- 
lected at the 25 % sucrose/ho- 
mogenization buffer inter- 
face, where ECVs formed in 
vivo equilibrate (Aniento et al., 1993a). Then, HRP activity was 
quantified in the fractions, and the fficiency of vesicle formation 
is expressed as a percentage of the total HRP activity originally 
present in the donor early endosomal fraction. Control, assay 
carried out at 37°C in the presence of cytosol and ATP; -ATP, 
ATP was omitted; -cytosol, cytosol was omitted; 4°C, the assay 
was at 4°C; GTPTS, 10 ~M GTP~/S was present in the assay. (B) 
The assay was carried out as in A for the indicated time periods. 
(C) The assay was as in A, but the fractions were analyzed by 
SDS-PAGE followed by Western blotting with antibodies 
against he transferrin receptor (TfnR), rab5 (rabS), ERGIC53 
and two different anti-13COP antibodies (M3A5 and El). FF, the 
floated fraction containing ECVs formed in vitro; PF, the pel- 
leted fraction containing donor early endosomes. For compari- 
son, endosomal fractions prepared as in Fig. 1 are also shown. 
EE, early endosomal fraction; LE, late endosomal fraction con- 
taining both late endosomes and ECVs (Aniento et al., 1993a). 
Each lane contained 15 Ixg protein, corresponding to ~-2× as 
much HRP in LE and FF fractions, when compared to EE and 
PF fractions, respectively. 
A morphological nalysis howed that the HRP-labeled 
structures present in the floated fraction were predomi- 
nantly multivesicular with the characteristic appearance of
ECVs, as expected, whereas the donor fraction contained 
a large proportion of typical tubular- and ring-shaped 
early endosomal elements (Fig. 4, A and B, see Table I). 
The complete assay mixture was then incubated without 
or with GTP~/S, which increases 13COP association to en- 
dosomes (Fig. 1 C) but blocks vesicle formation (Fig. 3 A), 
and then analysed by immunoelectron microscopy using 
anti-13COP antibodies (Fig. 4, C and D). Under both con- 
ditions, [3COP was detected on HRP-labeled early endo- 
somal membranes, including at the neck of multivesicular 
structures resembling forming ECVs. The epitope may be 
less accessible on the ECVs, since ECV labeling with these 
antibodies was low. Small (<100 nm) ~COP-coated vesi- 
cles with the characteristic appearance of biosynthetic 
COP-coated vesicles (see Kreis and Pepperkok, 1994) 
were not seen in these preparations. Nor did we observe 
an endosomal coat with the typical appearance of the 
Golgi COP coat, even after tannic acid treatment of the 
samples to enhance coat visualization (Orci et al., 1986). 
These experiments confirm the presence of [3COP on en- 
dosomes, but also suggest hat the endosomal COP coat 
does not only differ in composition but also in morphology 
and/or appearance from the biosynthetic COP coat. 
Endosomal Carrier Vesicles Formed In Vitro Are 
Fusogenic with Late Endosomes 
We had previously shown that ECVs formed in vivo un- 
dergo fusion with late endosomes in vitro, in contrast o 
early endosomes (Bomsel et al., 1990; Aniento et al., 
1993a). Here, we tested whether ECVs which were formed 
in vitro from early endosomes had acquired the capacity to 
undergo fusion with late endosomes. Fusion was measured 
by the formation of a fusion-specific omplex between 
bHRP and avidin (Gruenberg et al., 1989; Aniento et al., 
1993a). ECVs were formed in vitro exactly as described 
above (see Fig. 3, FF), except hat bHRP was used instead 
of HRP to label the endosomal content. As a control, we 
also measured the fusion properties of the bHRP-labeled 
donor early endosomes before (EE) and after (PF) bud- 
ding in vitro. In the fusion assay, the total bHRP activity of 
each fraction was identical to that of the ECV fraction, so 
that different experiments could be directly compared. 
Then, the bHRP-labeled vesicles were mixed with endo- 
somes containing internalized avidin (Aniento et al., 
1993a), cytosol and ATP, and then incubated for 45 min at 
37°C. If fusion occurred, a complex was formed between 
bHRP and avidin. At the end of the experiment, he com- 
plex was immunoprecipitated with anti-avidin antibodies 
in the presence of detergent and the enzymatic activity of 
bHRP was quantified. 
As shown in Fig. 5, ECVs formed in vitro have acquired 
the capacity to undergo fusion with late endosomes (FF- 
LE), fusion efficiency being similar to the value measured 
with freshly prepared ECVs (Aniento et al., 1993a). As 
previously reported for freshly prepared ECVs (Bomsel et 
al., 1990; Aniento et al., 1993a), interactions between 
ECVs formed in vitro and late endosomes were facilitated 
by the presence of polymerized microtubules (not shown). 
The donor membranes recovered after in vitro budding 
(PF) retained the typical capacity of the original early en- 
dosomes (EE) to undergo homotypic fusion with other 
early endosomal elements (PF-EE and EE-EE) (Gruen- 
berg et al., 1989). In addition, the direct fusion of donor 
membranes with late endosomes was comparatively ow, 
whether the donor was tested before (EE-LE) or after 
(PF-LE) the budding assay, in agreement with our previ- 
ous observations (Gorvel et al., 1991; Aniento et al., 
1993a). The low fusion signal which was then detected may 
be due to a low contamination of the early endosomal 
fraction with ECVs, or to the formation of new ECVs dur- 
ing the fusion assay (-~10% of the early endosomal vol- 
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Figure 4. Electron micros- 
copy analysis of donor mem- 
branes (PF) and vesicles 
formed in vitro (FF). (A and 
B) The assay was carried out 
as in Fig. 3 A, and then ana- 
lyzed after Epon embedding. 
Main panels show low mag- 
nification overviews of HRP- 
labeled elements in the pelleted 
(,4) and floated (B) fractions. 
The HRP-labeled profiles 
comprise tubules, ring-shaped 
structures (arrows) and spheri- 
cal multivesicular bodies (ar- 
rowheads). Early endosomal 
elements with a ty~pical ring- 
shaped appearance are present 
in the donor pelleted fraction 
(higher magnification i  inset 
to A). When compared to the 
donor pelleted fraction, the 
floated fraction is enriched in 
spherical multivesicular struc- 
tures (higher magnification i
insets to B, see Table I). Use of 
tannic acid in an attempt o 
stain coats associated with t e 
large vesicles revealed no sig- 
nificant COP-like coat. Some 
electron dense material was 
however associated with some 
multivesicular vesicles (B, in- 
set, small arrowheads). Bars, 
0.5 ~m (A-D) and 0.2 i~m (in- 
sets). (C and D) The assay was 
carried out as in Fig. 3 A in the presence of the M3A5 anti-13COP antibody with (D) or without (C) 10 I.LM GTP~/S. The mixture con- 
taining donor membranes was then incubated with second antibodies and protein A-gold, and embedded inEpon using a method to re- 
veal any coat material. Specific labeling is associated with HRP-labeled buds and tubules (large arrowheads) but rarely with the HRP- 
labeled multivesicular domains of early endosome (small double arrowheads). However, panels C (top right corner, no GTP~/S) and D 
(with GTP~S) show examples of 13COP labeling at the neck of structures resembling forming ECVs. Bars, 100 nm. 
ume is entrapped within newly formed ECVs in vitro; Fig. 
3 A). Our  data thus indicate that the fusion propert ies of 
both ECVs  formed in vitro and donor  endosomes (recov- 
ered after in vitro budding) are characteristic of the corre- 
sponding compartments  (Gorvel  et al., 1991; An iento  et 
al., 1993a) and establish that funct ional  ECVs are formed 
from early endosomes in vitro. 
Formation of  ECVs Depends on flCOP 
We then tested whether [3COP was involved in ECV for- 
mat ion from early endosomes. In these experiments,  vesi- 
cles were formed in vitro as described above, except that 
the react ion mixture was pre incubated for 60 rain on ice 
with ant ibodies against [3COP, before raising the tempera-  
ture to 37°C. As shown in Fig. 6 A, format ion of ECVs  was 
inhibited by a polyclonal (D1) or by a monoc lonal  (maD) 
ant ibody against the same [3COP peptide, or by an anti- 
coatomer ant ibody (CM1A10).  The process was also com- 
pletely abol ished by the M3A5 monoc lonal  ant ibody 
against [3COP. The specificity of inhibi t ion observed with 
these antibodies is entirely consistent with our other bio- 
chemical and morphological  observations. The maD and 
M3A5 could also be used for endosome immunoiso lat ion 
(Fig. 1, D and E) and immunolabe l ing  (Figs. 2 and 4), 
whereas the CM1A10 could be used for immunodep let ion  
of cytosolic COPs (see Fig. 6 C), as previously shown by 
Table I. Morphological Analysis of Donor Early Endosomes 
and Vesicles Formed In Vitro 
Tubular Ring-shaped Spherical Others 
% % % % 
Donor EE 25 31 40 4 
Budded vesicles 3 19 75 3 
Cells were incubated with HRP for 5 min at 37°C to label early endosomes, and ho- 
mogenized. Then, early endosomes were purified by flotation i the step gradient. In
the assay, these arly endosomes were incubated at 37°C in the presence of cytosol and 
ATP, to allow formation ofECVs to occur in vitro (as in Fig. 3). Donor early endo- 
somes were separated from ECVs after centrifugation n a similar g adient. Mem- 
branes were then sedimented, fixed, and processed for electron microscopy, asin 
(Gorvel et al., 1991). The profiles containing internalized HRP were analyzed. Ac- 
cording to their morphology in thick sections, HRP-positive structures were counted 
as tubular, ring-shaped, or spherical e ements (see Fig. 4). The number ofprofiles for 
each category is indicated as a percentage of the total number oflabeled structures in 
each fraction, donor early endosomes present inthe pelleted fraction (Donor EE) or 
vesicles formed in vitro present inthe floated fraction (Budded vesicles). 
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Figure 5. ECVs formed in vitro are fusogenic with late endo- 
somes. The assay measuring vesicle formation i  vitro was carried 
out essentially as in Fig. 3, except hat the reaction mixture (ad- 
justed to 25% sucrose) was loaded onto a 35% sucrose cushion to 
avoid possible damage to the donor membranes after pelleting. 
Thus, after centrifugation, donor early endosomal membranes 
(PF) were recovered at the 35/25% sucrose interface, whereas 
ECVs formed in vitro (FF) were collected at the interface be- 
tween 25% sucrose and homogenization buffer. In a second step, 
the fusion activity of FF and PF fractions with late endosomes 
(LE, see Fig. 1) was quantified using our in vitro fusion assay 
(Aniento et al., 1993a). The results are compared with the fusion 
activity of freshly prepared early endosomes (EE, see Fig. 1). The 
fusion assay itself is described in thetext and in the Materials and 
Methods section. The homotypic fusion activity of donor early 
endosomes with fresh early endosomes (PF-EE) is in the same 
range as the fusion activity of fresh early endosomes with each 
other (EE-EE). Neither donor early endosomes (PF-LE), nor 
fresh early endosomes (EE-LE) can undergo direct fusion with 
late endosomes, as expected (Aniento et al., 1993a). However, 
vesicles formed in vitro and present in the FF fraction have ac- 
quired the competence to undergo fusion with late endosomes 
(FF-LE), like bona fide ECVs (Aniento et al., 1993a). Hatched 
bars, with ATP; open bars, control without ATP. 
bodies, suggest that 13COP is involved in the formation of 
ECVs from early endosomes. 
As a next step, we tested the effects of COP depletion 
on vesicle formation in the assay. The cytosol was immu- 
nodepleted using the CM1A10 anti-coatomer antibody 
(Fig. 6 C), which has been previously used to immunode- 
plete coatomer (Orci et al., 1993b). After immunodeple- 
tion, other cytosolic properties required for vesicle forma- 
tion were not altered, since depleted cytosol supported the 
formation of ECVs from control untreated membranes 
(not shown). Since COPs are also present on endosomal 
membranes, cells were treated with nigericin before frac- 
tionation to release ndosome-associated COPs (Fig. 6 C; 
see below and Fig. 7 A). Membrane depletion was revers- 
ible, since vesicle formation then occurred at control evels 
in the presence of untreated cytosol when nigericin was 
omitted in the assay (Fig. 6 B, controls). 
Fig. 6 B shows that depletion of both cytosolic and mem- 
brane pools of 13COP significantly inhibited vesicle forma- 
tion in the assay. To ensure that these treatments were re- 
versible, low amounts of complete cytosol containing 
COPs were added to the assay. Then, vesicle formation 
from early endosomes was fully restored (Fig. 6 B). This 
effect was not due to the presence of some factors with 
general stimulating activity, since addition of extra cytosol 
to the controls did not further increase vesicle formation. 
To test the involvement of COP proteins more directly, a 
high speed pellet highly enriched in COPs was prepared 
after centrifugation of the cytosol (not shown), as estab- 
lished by F. Wieland (personal communication). Centrifu- 
gation did not alter other cytosolic properties, since the 
high speed supernatant s ill supported both ECV formation 
from undepleted membranes as well as endosome fusion 
in vitro (not shown). As shown in Fig. 6 B, the COP-enriched 
fraction could restore ECV formation after depletion of 
both cytosolic and membrane pools of COPs. Altogether, 
these depletion-recomplementation experiments, together 
with the effects of anti-13COP antibodies in the assay, dem- 
onstrate that COPs, in particular 13COP, are necessary for 
the formation of vesicles mediating transport from early to 
late endosomes. 
Orci et al. (1993b). In contrast, the A1 antibody had no ef- 
fect in the assay, suggesting that this epitope is not accessi- 
ble on endosomal membranes. 
As a control, we also tested in the assay antibodies 
against he small GTPase rab5, which inhibit early endo- 
some fusion in vitro (Gorvel et al., 1991), and against he 
small GTPase rab3a, which is present on synaptic vesicles 
(Fischer von Mollard et al., 1991). We also tested antibod- 
ies against clathrin-associated a adaptin, and against both 
131 and 132 adaptins (Robinson, 1992). None of these anti- 
bodies had any effect on ECV formation from early endo- 
somes (Fig. 6 A). Finally, as an additional control, we also 
tested the same antibodies in our assay measuring homo- 
typic fusion of early endosomes (Gruenberg et al., 1989). 
Whereas fusion was inhibited by anti-rab5 antibodies, as 
expected (Gorvel et al., 1991), none of the other antibod- 
ies, including those against 13COP, had any effect on endo- 
some fusion (not shown). The fact that anti-13COP anti- 
bodies block ECV formation from early endosomes but 
not early endosome fusion, in contrast to anti-rab5 anti- 
ECV Formation Is Sensitive to the Vacuolar pH 
Our previous observations had shown that ECV formation 
is abolished after inhibition of the vacuolar ATPase in 
vivo, whereas internalization into and recycling from early 
endosomes in vivo, or the fusion properties of early endo- 
somes in vitro are not affected (Clague et al., 1994). We 
therefore measured whether in vitro budding also re- 
quired an active vacuolar ATPase. In our assay, ECV for- 
mation was inhibited to the same extent in the presence of 
10 p~M bafilomycinA1 or 100 nM concanamycinB (Fig. 7 
A), two specific inhibitors of the vacuolar ATPase (Bow- 
man et al., 1988; Woo et al., 1992; Villa et al., 1993). The 
extent of inhibition was similar when cells were pre- 
treated with either drug in vivo, or when the drug was di- 
rectly added to the assay in vitro. However, a combination 
of both treatments caused a more pronounced inhibition, 
presumably because of a more efficient neutralization of 
the endosomal pH (Yoshimori et al., 1991; Clague et al., 
1994). In addition, replacement of KCI in the budding as- 
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Figure 6. ECV formation depends on 13COP. (A) The assay measuring ECV formation in vitro was carried out as described in the leg- 
end of Fig. 3, except that the mixture was preincubated for 60 ain on ice with the indicated antibodies. Control, no addition; P5D4, con- 
trol antibody as in Fig. 1 (D and E); anti-rab3a, ntibody against he small GTPase rab3a; anti-rab5, antibody against he small GTPase 
tab5; anti-a adaptin, antibody against a adaptin; a ti-ill ~2 adaptin, antibody against both 131 and 132 adaptins; M3A5, maD, A1, D1, an- 
tibodies against 13COP; CMIAIO, anti-coatomer antibody. Vesicle formation is expressed as a percentage of the controls. (B) Vesicle 
formation in vitro (as in Fig. 3) was measured after COP depletion. To deplete ndogenous COPs associated to endosomes, cells were 
pretreated with 10 ~M nigericin (see panel C and Fig. 7). This treatment was reversible, since ECV formation in vitro was restored by 
control rat liver cytosol, which had been incubated for 90 min with an irrelevant antibody (P5D4) and then for 1 h with protein A-Seph- 
arose coupled to rabbit anti-mouse IgG (control, see C). To deplete cytosolic oatomers, the cytosol was incubated as above, but with 
the CM1A10 anti-coatomer antibody (depleted, see C). ECV formation was inhibited after depletion of both endosomal nd cytosolic 
pools of COPs. ECV formation could be restored by the addition of 25% (Ixg/txg) untreated cytosol to the assay (complete cytosol), but 
not by COP-depleted cytosol (depleted cytosol). Addition of extra cytosol had no effects on the controls. ECV formation could also be 
restored after addition of a coatomer-enriched fraction prepared by high speed centrifugation of the cytosol (coatomer HSP). (C) SDS- 
gel and Western blotting analysis of 13 and eCOP distribution in cytosol and early endosomes (EE) prepared as in B. 
say with KOAc decreased the efficiency of vesicle bud- 
ding, in agreement with the role of Cl- channels in mainte- 
nance of an acidic lumenal pH (Mellman et al., 1986), and 
with the finding that loss of function of the cystic fibrosis 
transmembrane regulator, which causes defective C1- con- 
ductance, delays o~2-macroglobulin degradation (Barasch 
et al., 1991). Finally, we used nigericin, an ionophore 
which exchanges protons and K + ions, to dissect he aci- 
dogenic and electrogenic properties of the vacuolar ATP- 
ase (Mellman et al., 1986). The inhibition observed in the 
presence of the drug (Fig. 7 A) demonstrates that vesicle 
formation in vitro was inhibited by neutralization of the 
lumenal pH. 
[3COP Association to Endosomes I  Sensitive to the 
Vacuolar pH 
We then investigated whether 13COP association to endo- 
somal membranes was also sensitive to the lumenal pH. In 
these experiments, endosomes immunoisolated using the 
VSV-G protein as antigen were treated in the presence of 
cytosol under the same conditions as in the in vitro assay. 
A quantitative Western blot analysis using different anti- 
13COP antibodies howed that the amounts of 13COP asso- 
ciated to early endosomal membranes were reduced to 55 
_-+ 5% of the control value by bafilomycinA1, to 35 _+ 5% 
by concanamycinB, and to 15 _ 3% by nigericin (Fig. 7 B). 
We also used immunogold labeling and electron micros- 
copy to quantify the amounts of 13COP present on early 
endosomes after neutralization of the lumenal pH with 
concanamycinB or bafilomycinA1 (not shown). These 
studies also showed that only 30 _+ 8% of the amounts of 
13COP present on control membranes remained associated 
to early endosomes after either drug treatment. The drugs 
did not cause endosome fragmentation, since 100 __+ 5% of 
the transferrin receptor present in the control remained 
associated to immunoisolated ndosomes after each treat- 
ment (Fig. 7 B). Neither did the drugs release rab5, which 
normally cycles between cytosol and membranes (Zerial 
and Stenmark, 1993), or annexinlI, a peripheral protein of 
the early endosomal membrane (Emans et al., 1993); for 
both proteins, 95 _-+ 5% of the amounts present in the 
control remained associated to endosomes after each 
treatment. This lumenal pH dependence was specific to 
endosomes, since COP association, including ",/COP, to 
ERGIC53-containing membranes (HM in Fig. 1 A) was 
not affected by the drugs (not shown). Finally, these drugs 
also caused COPs to be released from endosomal mem- 
branes in vivo, as illustrated by the effects of nigericin on 13 
and ~COP (Fig. 6 C). Therefore, we conclude that the for- 
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Figure 7. ECV formation depends on an acidic endosomal pH. 
(A) The assay measuring ECV formation i  vitro was carried out 
as described in the legend of Fig. 3. A TP, in the presence of an 
ATP regenerating system (+) or an ATP-depleting system (-); 
Chloride, when indicated ( - )  KC1 was replaced with KOAc; Baf 
A1 in vivo, the cells were pre-treated with 1 p.M bafilomycin A1 
for 30 min at 37°C, before HRP internalization; BafA1, Con. B, 
and Nigericin, the donor early endosomal fraction was treated in 
vitro with the indicated concentrations f bafilomycin A1, con- 
canamycin B or nigericin for 15 rain at 4°C in the absence of ATP, 
and then for 15 min in the presence of ATP and cytosol, before 
raising the temperature to 37°C. (B) Immunoisolated arly endo- 
somes, prepared as in Fig. 1 B, were treated in vitro with 10 txM 
bafilomycin A1, 00 nM concanamycin B, or 50 p~M nigericin as 
in A. Then, endosomal membranes were collected by centrifuga- 
tion and analyzed by SDS-PAGE followed by Western blotting 
with the M3A5 or E1 antibodies against 13COP, or antibodies 
against rab5, the transferrin receptor and annexinlI. Each lane 
contained =10 txg protein. 
mation of ECVs from early endosomes depends on 13COP 
or a closely related 13COP homologue, and that this pro- 
cess is regulated by the acidification properties of early en- 
dosomes. 
Discussion 
We have previously shown that, both in polarized and 
nonpolarized cells, membrane transport from early to late 
endosomes occurs via vesicular intermediates which we 
termed ECVs (Gruenberg et al., 1989; Bomsel et al., 1990; 
Aniento et al., 1993a). Similar vesicles also mediate trans- 
port from early to late endosomes both in the axons and in 
the dendrites of cultured neurons (Parton et al., 1992). In 
this paper we show that some, but not all, COPs are 
present on endosomal membranes and are involved in the 
formation of ECVs from early endosomes in vitro. We ob- 
serve that neutralization of the endosomal pH either with 
specific inhibitors of the vacuolar ATPase or with the ion- 
ophore nigericin causes both a decrease in the amounts of 
COPs associated to early endosomes and an inhibition of 
the formation of ECVs from early endosomes. These ex- 
periments uggest hat a COP subcomplex is part of the 
mechanism regulating membrane transport from early to 
late endosomes, and that membrane association of endo- 
somal COPs depends on the acidic properties of the endo- 
somal milieu. 
Formation of ECVs from Early Endosomes 
We have used an in vitro assay to reconstitute the forma- 
tion of ECVs from early endosomes. We find that ~10% 
of a fluid phase tracer internalized for 5 min at 37°C in 
vivo is packaged within vesicles formed in vitro with a tla 
~5 min. Our previous tudies indicated that a similar frac- 
tion of the early endosomal content is packaged within 
ECVs over a 5-10-rain time period in vivo (Gruenberg et 
al., 1989). These observations may indicate that a single 
round of vesicle formation was reconstituted in the assay. 
This process depends on the presence of cytosol and ATP 
and is inhibited at low temperature. Vesicles formed in 
vitro do not originate from the simple fragmentation of
early endosomes, since they do not contain the small 
GTPase rab5, which is restricted to the plasma membrane 
and early endosomes in vivo even after 10--50-fold overex- 
pression (Chavrier et al., 1990, 1991; Gorvel et al., 1991). 
Nor are these vesicles recycling endosomal vesicles, since 
they lack the transferrin receptor, a marker of the recy- 
cling pathway (Hopkins, 1983; Stoorvogel et al., 1987; 
Mayor et al., 1993; Ghosh and Maxfield, 1995). Additional 
evidence that vesicles formed in vitro are not recycling 
vesicles comes from our observations that vesicle forma- 
tion is inhibited after neutralization of the lumenal pH, as 
is ECV formation in vivo. In contrast, recycling of the en- 
dosomal content back to the cell surface is not sensitive to 
the lumenal pH (Clague et al., 1994). Finally, evidence 
that functional ECVs are formed from early endosomes in
vitro comes from our observations that these vesicles are 
fusogenic with late endosomes, like ECVs formed in vivo 
(Aniento et al., 1993a; Bomsel et al., 1990). 
Our data argue against a gradual change of the mem- 
brane composition during passage from early to late endo- 
somes (Stoorvogel et al., 1991). Indeed, ECVs, but not do- 
nor early endosomes, have acquired the capacity to dock 
onto and fuse with late endosomes, and these ECVs ex- 
clude both rab5 and the transferrin eceptor. Our data, 
thus, suggest that a strict compartment boundary exists on 
early endosomal membranes atthe site of ECV formation. 
Coats and Endosomes 
With the exception of plasma membrane clathrin-coated 
pits, little is known about the role of coat proteins in the 
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endocytic pathway. Morphological studies have shown the 
presence of small clathrin-coated pits on early endosomal 
membranes, presumably involved in receptor ecycling 
back to the cell surface (Killisch et al., 1992). Non clathrin 
coats have also been observed on early endosomes (Par- 
ton, R., unpublished observations), but the function of 
these coats is unknown. In addition, expression of ~COP, a 
component of the COP coat required at early stages of the 
biosYnthetic pathway (Kreis and Pepperkok, 1994), was 
recently shown to correct pleiotropic membrane transport 
defects, including in the endocytic pathway, in the CHO 
ldlF mutant cell line (Guo et al., 1994; Hobbie et al., 1994). 
Our studies how that I3COP, another component of the 
COP coat, is present on early endosomes and is required 
for the formation of ECVs, the vesicular intermediates 
destined for late endosomes. Consistent with the findings 
of Guo et al. (1994), we find that ~COP is also present on 
endosomes. However, all COP subunits do not appear to 
be shared by the endocytic and the biosynthetic pathways, 
since ~,COP is not detected in any of our different endo- 
some preparations. These observations are also in good 
agreement with the finding that [3, ~, and [COP, but not 
~COP, are associated to endosomes prepared by free-flow 
electrophoresis (Whitney, J.A., M. Gomez, T.E. Kreis, and 
I. Mellman, manuscript submitted for publication). Al- 
though the precise function of endosomal COPs is not es- 
tablished, our data, examined in the light of the known 
roles of coat proteins (Kreis and Pepperkok, 1994; Robin- 
son, 1994), suggest hat endosomal COPs contribute to 
coat formation during vesicle transport from early to late 
endosomes. 
Endosomal nd Biosynthetic COPs 
We find that some, but not all, antibodies against [3COP 
can inhibit ECV formation in vitro, suggesting that some 
epitopes only are accessible to antibodies when the pro- 
tein is bound to endosomal membranes. These observa- 
tions may also suggest hat endosomal and biosynthetic 
forms of [3COP are, at least to some extent, immunologi- 
cally distinct. Indeed, several [3COP isoforms have been 
found in high resolution two-dimensional gels (Celis et al., 
1994), presumably reflecting the existence of different 
post-translational modifications. More importantly, the 
presence of [3, [, and ¢COP, but not "yCOP, on endosomes 
suggests that coatomer subcomplexes can exist, and that 13, 
[, and ¢COP may be part of the same subcomplex on en- 
dosomal membranes. Presumably, this subcomplex is asso- 
ciated to other, as yet unknown, components on endoso- 
real membranes. 
The mechanisms regulating both COP association to en- 
dosomes and ECV formation differ, at least o some ex- 
tent, from those regulating the formation of COP-coated 
vesicles in the biosynthetic pathway. Both ECV formation 
and COP association to endosomes are sensitive to the lu- 
menal pH. In contrast, biosynthetic COP-coated vesicles 
form on the membranes ofnonacidic ompartments (Mell- 
man et al., 1986), and COP association to ERGIC53- 
enriched membranes i pH insensitive. We also find that 
ECV formation is inhibited by GTP~tS, as is the formation 
of plasma membrane-derived clathrin-coated vesicles (Carter 
et al., 1993) and secretory granules (Tooze et al., 1990), 
but in contrast o the budding of COP- or COPII-coated 
vesicles (Ostermann et al., 1993; Barlowe et al., 1994). How- 
ever, COP binding to endosomes i  increased by GTP-/S, 
as is the case for Golgi membranes (Donaldson et al., 
1990; Donaldson et al., 1992; Helms and Rothman, 1992; 
Palmer et al., 1993). On Golgi membranes, both COP re- 
cruitment and vesicle formation are stimulated by GTP'yS 
via the small GTP-binding protein ARF1 (see Kreis and 
Pepperkok, 1994). Since we find that GTP~/S stimulates 
COP association to endosomes but inhibits ECV forma- 
tion, it appears that these two processes are uncoupled in 
the endocytic pathway, presumably because they are regu- 
lated by more than one GTP-binding protein. Alterna- 
tively, COP association to endosomes may be regulated by 
an ARF with properties distinct from ARF1. Indeed, 
membrane association of ARF6, which has been impli- 
cated between plasma membrane and early endosomes, 
does not depend on the bound nucleotide state and is in- 
sensitive to brefeldinA, in contrast to ARF1 (Peters et al., 
1994). 
Altogether, our observations indicate that the associa- 
tion of endosomal and biosynthetic COPs to membranes 
shares imilar GTP dependence but is regulated, at least in 
part, by different mechanisms. Since COP subunits are 
only partially shared by endosomal nd biosynthetic mem- 
branes, one may speculate that mechanistic similarities 
and differences reflect the presence of common and spe- 
cific coat components, respectively. 
Acidification, Membrane Transport, and COPs 
Our data show that COPs are directly involved in the for- 
mation of ECVs. Neutralization of the endosomal pH re- 
duces the amounts of COPs associated to endosomal 
membranes, and concomitantly inhibits the formation of 
ECVs in vitro, as we had observed in vivo (Clague et al., 
1994). These observations suggest hat the acidification 
properties of BHK early endosomes may control the for- 
mation of vesicles destined for late endosomes by control- 
ling coat recruitment onto the membranes. This mecha- 
nism is consistent with the fact that the lumenal pH drops 
from early to late endosomes (Mellman et al., 1986) and 
with the observation that ECVs can be more acidic than 
early endosomes (Killisch et al., 1992). It is not clear how 
information on the lumenal pH may then be transferred to 
the cytoplasmic face of the membrane. The simplest view 
is that pH differences may be sensed by the conforma- 
tional change of a membrane protein. Indeed, the confor- 
mation of trans-membrane proteins can be sensitive to the 
endosomal pH (Watts, 1984). We, therefore, speculate 
that the conformation of an endosomal trans-membrane 
protein, possibly a COP receptor, ispH sensitive, and thus 
serves as a sensor of the endosomal pH. 
In conclusion, formation of transport vesicles at the 
early endosomal membrane appears to be regulated by 
COP recruitment on the membrane in a process depen- 
dent on the acidic milieu of early endosomes. This mecha- 
nism, which is also regulated by GTP-binding proteins, but 
not by tab5 present on early endosomes, may provide an 
appropriate means to regulate the formation of these rela- 
tively large and multivesicular carriers (Gruenberg et al., 
1989; Bomsel et al., 1990; Aniento et al., 1993a). One of 
Aniento et al. BCOP and pH in Endosomal Transport 39 
our future goals will be to make use of our approach to 
study in more detail the formation of these vesicular inter- 
mediates, and, in particular, the precise role of coat pro- 
teins in this process. 
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